Whistleblowers sue Wyeth over Rapamune marketing

A pair of former hospital sales reps filed a whistleblower suit alleging Wyeth, which is now owned by Pfizer, illegally promoted its Rapamune kidney transplant drug for off-label use with other organ transplants. Report